4. S100B Protein Content In Ischemic Stroke And Its Prognostic Value In Patients Subjected To Invasive Interventions

Authors

  • A.A. Baubekov Kazakh National Medical University named after S.D. Asfendiyarov, Almaty, Kazakhstan, International Medical Center «Private Clinic Almaty», Almaty, Kazakhstan
  • T.K. Tajibayev International Medical Center «Private Clinic Almaty», Almaty, Kazakhstan
  • Ye.M. Miyerbekov National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan
  • T.Zh. Egemberdiev Kazakh National Medical University named after S.D. Asfendiyarov, Almaty, Kazakhstan
  • D. Berikuly Semey Medical University, Semey, Kazakhstan
  • I.Y. Sagatov National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan
  • N.B. Omarov Semey Medical University, Semey, Kazakhstan

DOI:

https://doi.org/10.35805/BSK2023III004

Downloads

Abstract

The aim of the study is to determine the levels of the S100B protein in patients with ischemic stroke and evaluate its relationship with the size of brain tissue damage, stroke severity, and clinical outcomes..

Materials and methods. The study included 113 patients with acute ischemic stroke, hospitalized within the first day after its onset and subjected to invasive treatment. 101 men and 12 women were examined, including 32 at the age of 50-60, 64 at the age of 61-70, 17 at the age of 71-80. parameters and degree of functional deviations according to the NIHSS scale..

Results. The content of S100B during the initial determination on average for the group significantly exceeded the level determined in the control by 3.22 times (p=0.025). There was a direct dependence of the content of S100B on the size of the stroke. A moderate increase in the indicator on the 3rd day relative to the determined one on the 1st day and a decrease on the 7th day after the development of the stroke were revealed. There was no significant dependence of S100B content on the presence of comorbidities. The influence of the studied parameter on the degree of neurological deficit was determined only in patients with a large stroke size.

Keywords

ischemic stroke, protein S100B

References

  1. Towfighi A, Ovbiagele B. Health Equity and Actionable Disparities in Stroke: 2021 Update. Stroke. 2022 Mar;53(3):636-642. doi:10.1161/STROKEAHA.122.035816
  2. Russo E. et al. Mitochondrial targeting as a novel therapy for stroke. Brain circulation. 2018; 4(3):84
  3. Rexrode KM, Madsen TE, Yu AYX, Carcel C, Lichtman JH, Miller EC. The Impact of Sex and Gender on Stroke. Circ Res. 2022 Feb 18;130(4):512-528. doi:10.1161/CIRCRESAHA.121.319915
  4. Holst, C. B., Brøchner, C. B., Vitting‐Seerup, K., & Møllgård, K. Astrogliogenesis in human fetal brain: complex spatiotemporal immunoreactivity patterns of GFAP, S100, AQP 4 and YKL‐40. Journal of Anatomy, 2019;235(3):590-615
  5. Gao L. et al. Neuron-specific enolase in hypertension patients with acute ischemic stroke and its value forecasting long-term functional outcomes. BMC geriatrics. 2023:23(1):294
  6. Gonzalez L.L., Garrie K., Turner M.D. Role of S100 proteins in health and disease. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2020;1867(6):118677
  7. Michetti F. et al. The S100B story: from biomarker to active factor in neural injury. Journal of neurochemistry. 2019;148(2):168-187
  8. Mokhtarzade M. et al. Exercise-induced changes in neurotrophic factors and markers of blood-brain barrier permeability are moderated by weight status in multiple sclerosis. Neuropeptides.2018;70:93-100
  9. Abbas N. I. et al. D-dimer level is correlated with prognosis, infarct size, and NIHSS in acute ischemic stroke patients. Indian Journal of Critical Care Medicine: Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine. 2021;25(2):193
  10. Jose J., James J. An MRI based ischemic stroke classification–A mechanism oriented approach. Annals of Indian Academy of Neurology. 2022;25(6):1019
  11. Matsuo H. et al. Dysphagia is associated with functional decline during acute‐care hospitalization of older patients. Geriatrics & Gerontology International. 2017;17(10):1610-1616
  12. Miao Y., Liao J.K. Potential serum biomarkers in the pathophysiological processes of stroke. Expert review of neurotherapeutics. 2017;14(2):173-185
  13. He Y, Cai Z, Chen Y. Role of S-100β in stroke. Int J Neurosci. 2018 Dec;128(12):1180-1187. doi:10.1080/00207454.2018.1481065
  14. De Vos A. et al. Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke. BMC neurology. 2017;17:1-8

Published

2023-08-10

Issue

No. 3 (2023)

Section

Статьи